One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors
Read more
bestallergymedicinehq.org
Home »
One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors
Read moreinsights from industryDr. Marcos Quintela VasquezResearch and Development Innovation OfficerRBGO Research Group In this interview, News-Medical talks to Dr. Marcos
Read moreResearchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variants in the BRCA2
Read moreIn a proof-of-concept study, an international scientific team led by Johns Hopkins Kimmel Cancer Center researchers has shown that a
Read moreA modelling study published in The Lancet Oncology journal estimates that there are almost 400,000 new cases of childhood cancer
Read moreMYC, a gene with high cancer-initiating potential, is overexpressed in over 40% of breast cancers. While MYC programs breast cancer
Read moreWomen may not need to undergo surgery for non-cancerous ovarian cysts, avoiding potential surgical complications. This is the finding of
Read moreThe most comprehensive genome-wide association study, or GWAS, of colorectal cancer risk to date, published today in Nature Genetics, has
Read more